Skip to content

Author

B. Medhi

We have 1 of 26 papers

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Review Aug 2026

HMGB1 signalling in Alzheimer's disease: pathogenic roles and therapeutic prospects.

High mobility group box 1 (HMGB1) is a crucial modulator of neuroinflammation in AD, according to new research, and a viable treatment approach for reducing neuroinflammation and associated pathologies with AD is to target HMGB1-mediated signalling networks.

Prashant Tyagi, Sneha Kumari, Prajjwal Sharma et al. · 1 citation

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.